APO Research

APO RESEARCH · REPORT

Neural Control Interface

Neuro-controlled BRAIN-machine interfaces are the direct connections created between the human or animal brain (or culture of brain cells) and external devices.

Product & engineering

Understand the product.

Neuro-controlled BRAIN-machine interfaces are the direct connections created between the human or animal brain (or culture of brain cells) and external devices.

In the case of a one-way BRAIN-computer interface, the computer either receives commands from the brain or sends signals to the brain (such as video reconstruction), but not both.

Bidirectional BRAIN-computer interfaces allow two-way information exchange between the brain and external devices.

Selected research

Market Outlook & Growth Opportunities

Global Neural Control Interface Market Outlook and Growth Opportunities 2026

Market perspective

Neuro-controlled BRAIN-machine interfaces are the direct connections created between the human or animal brain (or culture of brain cells) and external devices.

In the case of a one-way BRAIN-computer interface, the computer either receives commands from the brain or sends signals to the brain (such as video reconstruction), but not both.

Bidirectional BRAIN-computer interfaces allow two-way information exchange between the brain and external devices.

Read the full market overview

The first category, mainly non-invasive BRAIN-computer interfaces, has a relatively large share of the global market, accounting for about 87.04% in 2019.

The other major category is invasive BRAIN-computer interfaces, which are attractive to many companies because they can implement more complex functions in the future.The leading players in the BCI market are NeuroPace Inc., Mindmaze SA, Ctrl-Labs (Facebook), BrainCo, Brain Products GmbH, G.MAZE, Emotiv Inc, Blackrock Microsystems LLC, InteraXon, NeuroSky, Inc.

These top companies now account for more than 57 per cent of the total market share and are expected to maintain their dominance over the forecast period.

But it is also more technically difficult.

Invasive BCI technology will account for 12.24% of the market by 2020.

From the regional perspective, the North American market share in 2019 is large, accounting for 62.10% of the market, which will maintain steady growth in the next few years.

Europe and China, with market shares of 28.12% and 2.94% respectively, will continue to play an important role that cannot be ignored.

This report provides an overview of the global Neural Control Interface market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neural Control Interface and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neural Control Interface revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neural Control Interface market.

Neural Control Interface Segment by Company

NeuroPace Inc

Mindmaze SA

CTRL-Labs (Facebook)

BrainCo

Brain Products GmbH

G.TEC

Emotiv Inc

Blackrock Microsystems LLC

InteraXon

NeuroSky, Inc.

Compumedics Limited

Neurable

Advanced Brain Monitoring

ANT Neuro B.V

Neuroelectrics

Artinis Medical Systems BV

Neural Control Interface Segment by Type

Invasive

Noninvasive

Neural Control Interface Segment by Application

Health Care

Games and Entertainment

Communication

Other

Neural Control Interface Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neural Control Interface status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neural Control Interface key companies, revenue, market share, and recent developments.

3. To split the Neural Control Interface breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neural Control Interface market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neural Control Interface significant trends, drivers, influence factors in global and regions.

6. To analyze Neural Control Interface competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neural Control Interface market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neural Control Interface and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neural Control Interface.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neural Control Interface industry.

Chapter 3: Detailed analysis of Neural Control Interface company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neural Control Interface in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neural Control Interface in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neural Control Interface Industry Trends Table 2. Neural Control Interface Industry Drivers Table 3. Neural Control Interface Industry Opportunities and Challenges Table 4. Neural Control Interface Industry Restraints Table 5. Global Neural Control Interface Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neural Control Interface Revenue Share by Company (2021-2026) Table 7. Global Neural Control Interface Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neural Control Interface Key Company Manufacturing Base & Headquarters Table 9. Global Neural Control Interface Company, Product Type & Application Table 10. Global Neural Control Interface Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neural Control Interface by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Invasive Table 15. Significant Companies of Noninvasive Table 16. Global Neural Control Interface Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Neural Control Interface Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Neural Control Interface Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Neural Control Interface Sales Value Share by Type (2021-2026) Table 20. Global Neural Control Interface Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Health Care Table 22. Significant Companies of Games and Entertainment Table 23. Significant Companies of Communication Table 24. Significant Companies of Other Table 25. Global Neural Control Interface Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Neural Control Interface Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Neural Control Interface Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Neural Control Interface Sales Value Share by Application (2021-2026) Table 29. Global Neural Control Interface Sales Value Share by Application (2027-2032) Table 30. Global Neural Control Interface Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Neural Control Interface Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Neural Control Interface Sales Value Share by Region (2021-2026) Table 33. Global Neural Control Interface Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Neural Control Interface Sales Value Share by Region (2027-2032) Table 35. Global Neural Control Interface Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Neural Control Interface Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Neural Control Interface Sales Value Market Share by Country (2021-2026) Table 38. Global Neural Control Interface Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Neural Control Interface Sales Value Market Share by Country (2027-2032) Table 40. NeuroPace Inc Company Information Table 41. NeuroPace Inc Business Overview Table 42. NeuroPace Inc Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. NeuroPace Inc Neural Control Interface Product Portfolio Table 44. NeuroPace Inc Recent Development Table 45. Mindmaze SA Company Information Table 46. Mindmaze SA Business Overview Table 47. Mindmaze SA Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Mindmaze SA Neural Control Interface Product Portfolio Table 49. Mindmaze SA Recent Development Table 50. CTRL-Labs (Facebook) Company Information Table 51. CTRL-Labs (Facebook) Business Overview Table 52. CTRL-Labs (Facebook) Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. CTRL-Labs (Facebook) Neural Control Interface Product Portfolio Table 54. CTRL-Labs (Facebook) Recent Development Table 55. BrainCo Company Information Table 56. BrainCo Business Overview Table 57. BrainCo Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. BrainCo Neural Control Interface Product Portfolio Table 59. BrainCo Recent Development Table 60. Brain Products GmbH Company Information Table 61. Brain Products GmbH Business Overview Table 62. Brain Products GmbH Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Brain Products GmbH Neural Control Interface Product Portfolio Table 64. Brain Products GmbH Recent Development Table 65. G.TEC Company Information Table 66. G.TEC Business Overview Table 67. G.TEC Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. G.TEC Neural Control Interface Product Portfolio Table 69. G.TEC Recent Development Table 70. Emotiv Inc Company Information Table 71. Emotiv Inc Business Overview Table 72. Emotiv Inc Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Emotiv Inc Neural Control Interface Product Portfolio Table 74. Emotiv Inc Recent Development Table 75. Blackrock Microsystems LLC Company Information Table 76. Blackrock Microsystems LLC Business Overview Table 77. Blackrock Microsystems LLC Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Blackrock Microsystems LLC Neural Control Interface Product Portfolio Table 79. Blackrock Microsystems LLC Recent Development Table 80. InteraXon Company Information Table 81. InteraXon Business Overview Table 82. InteraXon Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. InteraXon Neural Control Interface Product Portfolio Table 84. InteraXon Recent Development Table 85. NeuroSky, Inc. Company Information Table 86. NeuroSky, Inc. Business Overview Table 87. NeuroSky, Inc. Neural Control Interface Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. NeuroSky, Inc. Neural Control Interface Product Portfolio Table 89. NeuroSky, Inc. Recent Development Table 90. Compumedics Limited Company Information Table 91. Compumedics Limited Business Overview Table 92. Compumedics Limited Neural Control Interface Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Compumedics Limited Neural Control Interface Product Portfolio Table 94. Compumedics Limited Recent Development Table 95. Neurable Company Information Table 96. Neurable Business Overview Table 97. Neurable Neural Control Interface Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Neurable Neural Control Interface Product Portfolio Table 99. Neurable Recent Development Table 100. Advanced Brain Monitoring Company Information Table 101. Advanced Brain Monitoring Business Overview Table 102. Advanced Brain Monitoring Neural Control Interface Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Advanced Brain Monitoring Neural Control Interface Product Portfolio Table 104. Advanced Brain Monitoring Recent Development Table 105. ANT Neuro B.V Company Information Table 106. ANT Neuro B.V Business Overview Table 107. ANT Neuro B.V Neural Control Interface Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. ANT Neuro B.V Neural Control Interface Product Portfolio Table 109. ANT Neuro B.V Recent Development Table 110. Neuroelectrics Company Information Table 111. Neuroelectrics Business Overview Table 112. Neuroelectrics Neural Control Interface Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Neuroelectrics Neural Control Interface Product Portfolio Table 114. Neuroelectrics Recent Development Table 115. Artinis Medical Systems BV Company Information Table 116. Artinis Medical Systems BV Business Overview Table 117. Artinis Medical Systems BV Neural Control Interface Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Artinis Medical Systems BV Neural Control Interface Product Portfolio Table 119. Artinis Medical Systems BV Recent Development Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Neural Control Interface Product Image Figure 2. Global Neural Control Interface Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neural Control Interface Market Size (2021-2032) & (US$ Million) Figure 4. Global Neural Control Interface Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Invasive Image Figure 8. Noninvasive Image Figure 9. Global Neural Control Interface Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Neural Control Interface Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Neural Control Interface Sales Value Share by Type (2021-2032) Figure 12. Health Care Image Figure 13. Games and Entertainment Image Figure 14. Communication Image Figure 15. Other Image Figure 16. Global Neural Control Interface Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Neural Control Interface Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Neural Control Interface Sales Value Share by Application (2021-2032) Figure 19. Global Neural Control Interface Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Neural Control Interface Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Neural Control Interface Sales Value (2021-2032) & (US$ Million) Figure 22. North America Neural Control Interface Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Neural Control Interface Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Neural Control Interface Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Neural Control Interface Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Neural Control Interface Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Neural Control Interface Sales Value (2021-2032) & (US$ Million) Figure 28. South America Neural Control Interface Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Neural Control Interface Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Neural Control Interface Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Neural Control Interface Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Neural Control Interface Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Neural Control Interface Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Invasive
  • Noninvasive
Applications
  • Health Care
  • Games and Entertainment
  • Communication
  • Other
Companies covered
  • NeuroPace Inc
  • Mindmaze SA
  • CTRL-Labs (Facebook)
  • BrainCo
  • Brain Products GmbH
  • G.TEC
  • Emotiv Inc
  • Blackrock Microsystems LLC
  • InteraXon
  • NeuroSky, Inc.
  • Compumedics Limited
  • Neurable
  • Advanced Brain Monitoring
  • ANT Neuro B.V
  • Neuroelectrics
  • Artinis Medical Systems BV

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neural Control Interface Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neural Control Interface Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neural Control Interface Market Dynamics
  1. 2.1 Neural Control Interface Industry Trends
  2. 2.2 Neural Control Interface Industry Drivers
  3. 2.3 Neural Control Interface Industry Opportunities and Challenges
  4. 2.4 Neural Control Interface Industry Restraints
3 Neural Control Interface Market by Company
  1. 3.1 Global Neural Control Interface Company Revenue Ranking in 2025
  2. 3.2 Global Neural Control Interface Revenue by Company (2021-2026)
  3. 3.3 Global Neural Control Interface Company Ranking (2024-2026)
  4. 3.4 Global Neural Control Interface Company Manufacturing Base and Headquarters
  5. 3.5 Global Neural Control Interface Company Product Type and Application
  6. 3.6 Global Neural Control Interface Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neural Control Interface Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neural Control Interface Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neural Control Interface Market by Type
  1. 4.1 Neural Control Interface Type Introduction
  2. 4.1.1 Invasive
  3. 4.1.2 Noninvasive
  4. 4.2 Global Neural Control Interface Sales Value by Type
  5. 4.2.1 Global Neural Control Interface Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Neural Control Interface Sales Value by Type (2021-2032)
  7. 4.2.3 Global Neural Control Interface Sales Value Share by Type (2021-2032)
5 Neural Control Interface Market by Application
  1. 5.1 Neural Control Interface Application Introduction
  2. 5.1.1 Health Care
  3. 5.1.2 Games and Entertainment
  4. 5.1.3 Communication
  5. 5.1.4 Other
  6. 5.2 Global Neural Control Interface Sales Value by Application
  7. 5.2.1 Global Neural Control Interface Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Neural Control Interface Sales Value by Application (2021-2032)
  9. 5.2.3 Global Neural Control Interface Sales Value Share by Application (2021-2032)
6 Neural Control Interface Regional Value Analysis
  1. 6.1 Global Neural Control Interface Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neural Control Interface Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neural Control Interface Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neural Control Interface Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neural Control Interface Sales Value (2021-2032)
  7. 6.3.2 North America Neural Control Interface Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neural Control Interface Sales Value (2021-2032)
  10. 6.4.2 Europe Neural Control Interface Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neural Control Interface Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neural Control Interface Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neural Control Interface Sales Value (2021-2032)
  16. 6.6.2 South America Neural Control Interface Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neural Control Interface Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neural Control Interface Sales Value Share by Country, 2025 VS 2032
7 Neural Control Interface Country-level Value Analysis
  1. 7.1 Global Neural Control Interface Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neural Control Interface Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neural Control Interface Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neural Control Interface Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neural Control Interface Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neural Control Interface Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neural Control Interface Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neural Control Interface Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neural Control Interface Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neural Control Interface Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neural Control Interface Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neural Control Interface Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neural Control Interface Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neural Control Interface Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neural Control Interface Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neural Control Interface Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neural Control Interface Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neural Control Interface Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neural Control Interface Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neural Control Interface Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neural Control Interface Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neural Control Interface Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neural Control Interface Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neural Control Interface Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neural Control Interface Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neural Control Interface Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neural Control Interface Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neural Control Interface Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neural Control Interface Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neural Control Interface Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neural Control Interface Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neural Control Interface Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neural Control Interface Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neural Control Interface Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neural Control Interface Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 NeuroPace Inc
  2. 8.1.1 NeuroPace Inc Company Information
  3. 8.1.2 NeuroPace Inc Business Overview
  4. 8.1.3 NeuroPace Inc Neural Control Interface Revenue and Gross Margin (2021-2026)
  5. 8.1.4 NeuroPace Inc Neural Control Interface Product Portfolio
  6. 8.1.5 NeuroPace Inc Recent Developments
  7. 8.2 Mindmaze SA
  8. 8.2.1 Mindmaze SA Company Information
  9. 8.2.2 Mindmaze SA Business Overview
  10. 8.2.3 Mindmaze SA Neural Control Interface Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mindmaze SA Neural Control Interface Product Portfolio
  12. 8.2.5 Mindmaze SA Recent Developments
  13. 8.3 CTRL-Labs (Facebook)
  14. 8.3.1 CTRL-Labs (Facebook) Company Information
  15. 8.3.2 CTRL-Labs (Facebook) Business Overview
  16. 8.3.3 CTRL-Labs (Facebook) Neural Control Interface Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CTRL-Labs (Facebook) Neural Control Interface Product Portfolio
  18. 8.3.5 CTRL-Labs (Facebook) Recent Developments
  19. 8.4 BrainCo
  20. 8.4.1 BrainCo Company Information
  21. 8.4.2 BrainCo Business Overview
  22. 8.4.3 BrainCo Neural Control Interface Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BrainCo Neural Control Interface Product Portfolio
  24. 8.4.5 BrainCo Recent Developments
  25. 8.5 Brain Products GmbH
  26. 8.5.1 Brain Products GmbH Company Information
  27. 8.5.2 Brain Products GmbH Business Overview
  28. 8.5.3 Brain Products GmbH Neural Control Interface Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Brain Products GmbH Neural Control Interface Product Portfolio
  30. 8.5.5 Brain Products GmbH Recent Developments
  31. 8.6 G.TEC
  32. 8.6.1 G.TEC Company Information
  33. 8.6.2 G.TEC Business Overview
  34. 8.6.3 G.TEC Neural Control Interface Revenue and Gross Margin (2021-2026)
  35. 8.6.4 G.TEC Neural Control Interface Product Portfolio
  36. 8.6.5 G.TEC Recent Developments
  37. 8.7 Emotiv Inc
  38. 8.7.1 Emotiv Inc Company Information
  39. 8.7.2 Emotiv Inc Business Overview
  40. 8.7.3 Emotiv Inc Neural Control Interface Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Emotiv Inc Neural Control Interface Product Portfolio
  42. 8.7.5 Emotiv Inc Recent Developments
  43. 8.8 Blackrock Microsystems LLC
  44. 8.8.1 Blackrock Microsystems LLC Company Information
  45. 8.8.2 Blackrock Microsystems LLC Business Overview
  46. 8.8.3 Blackrock Microsystems LLC Neural Control Interface Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Blackrock Microsystems LLC Neural Control Interface Product Portfolio
  48. 8.8.5 Blackrock Microsystems LLC Recent Developments
  49. 8.9 InteraXon
  50. 8.9.1 InteraXon Company Information
  51. 8.9.2 InteraXon Business Overview
  52. 8.9.3 InteraXon Neural Control Interface Revenue and Gross Margin (2021-2026)
  53. 8.9.4 InteraXon Neural Control Interface Product Portfolio
  54. 8.9.5 InteraXon Recent Developments
  55. 8.10 NeuroSky, Inc.
  56. 8.10.1 NeuroSky, Inc. Company Information
  57. 8.10.2 NeuroSky, Inc. Business Overview
  58. 8.10.3 NeuroSky, Inc. Neural Control Interface Revenue and Gross Margin (2021-2026)
  59. 8.10.4 NeuroSky, Inc. Neural Control Interface Product Portfolio
  60. 8.10.5 NeuroSky, Inc. Recent Developments
  61. 8.11 Compumedics Limited
  62. 8.11.1 Compumedics Limited Company Information
  63. 8.11.2 Compumedics Limited Business Overview
  64. 8.11.3 Compumedics Limited Neural Control Interface Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Compumedics Limited Neural Control Interface Product Portfolio
  66. 8.11.5 Compumedics Limited Recent Developments
  67. 8.12 Neurable
  68. 8.12.1 Neurable Company Information
  69. 8.12.2 Neurable Business Overview
  70. 8.12.3 Neurable Neural Control Interface Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Neurable Neural Control Interface Product Portfolio
  72. 8.12.5 Neurable Recent Developments
  73. 8.13 Advanced Brain Monitoring
  74. 8.13.1 Advanced Brain Monitoring Company Information
  75. 8.13.2 Advanced Brain Monitoring Business Overview
  76. 8.13.3 Advanced Brain Monitoring Neural Control Interface Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Advanced Brain Monitoring Neural Control Interface Product Portfolio
  78. 8.13.5 Advanced Brain Monitoring Recent Developments
  79. 8.14 ANT Neuro B.V
  80. 8.14.1 ANT Neuro B.V Company Information
  81. 8.14.2 ANT Neuro B.V Business Overview
  82. 8.14.3 ANT Neuro B.V Neural Control Interface Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ANT Neuro B.V Neural Control Interface Product Portfolio
  84. 8.14.5 ANT Neuro B.V Recent Developments
  85. 8.15 Neuroelectrics
  86. 8.15.1 Neuroelectrics Company Information
  87. 8.15.2 Neuroelectrics Business Overview
  88. 8.15.3 Neuroelectrics Neural Control Interface Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Neuroelectrics Neural Control Interface Product Portfolio
  90. 8.15.5 Neuroelectrics Recent Developments
  91. 8.16 Artinis Medical Systems BV
  92. 8.16.1 Artinis Medical Systems BV Company Information
  93. 8.16.2 Artinis Medical Systems BV Business Overview
  94. 8.16.3 Artinis Medical Systems BV Neural Control Interface Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Artinis Medical Systems BV Neural Control Interface Product Portfolio
  96. 8.16.5 Artinis Medical Systems BV Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research